{"title":"溶瘤病毒：癌症治疗的下一个重大突破","authors":"M. Ferhat","doi":"10.15406/jhvrv.2017.05.00141","DOIUrl":null,"url":null,"abstract":"Submit Manuscript | http://medcraveonline.com only recently that clinical trials demonstrated the effectiveness of OVs in humans with recent US Food and Drug Administration (FDA) approval of an oncolytic virus in advanced melanoma [2]. Oncolytic viruses open a new era in cancer treatment. This short article provides a comprehensive overview of Oncolytic viruses, their use as cancer therapeutic agents and discusses the future and the challenges in the development of oncolytic viruses as a new therapeutic approach in cancer treatment.","PeriodicalId":92670,"journal":{"name":"Journal of human virology & retrovirology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2017-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Oncolytic Viruses: The Next Major Breakthrough in Cancer Treatment\",\"authors\":\"M. Ferhat\",\"doi\":\"10.15406/jhvrv.2017.05.00141\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Submit Manuscript | http://medcraveonline.com only recently that clinical trials demonstrated the effectiveness of OVs in humans with recent US Food and Drug Administration (FDA) approval of an oncolytic virus in advanced melanoma [2]. Oncolytic viruses open a new era in cancer treatment. This short article provides a comprehensive overview of Oncolytic viruses, their use as cancer therapeutic agents and discusses the future and the challenges in the development of oncolytic viruses as a new therapeutic approach in cancer treatment.\",\"PeriodicalId\":92670,\"journal\":{\"name\":\"Journal of human virology & retrovirology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-02-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of human virology & retrovirology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15406/jhvrv.2017.05.00141\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of human virology & retrovirology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15406/jhvrv.2017.05.00141","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Oncolytic Viruses: The Next Major Breakthrough in Cancer Treatment
Submit Manuscript | http://medcraveonline.com only recently that clinical trials demonstrated the effectiveness of OVs in humans with recent US Food and Drug Administration (FDA) approval of an oncolytic virus in advanced melanoma [2]. Oncolytic viruses open a new era in cancer treatment. This short article provides a comprehensive overview of Oncolytic viruses, their use as cancer therapeutic agents and discusses the future and the challenges in the development of oncolytic viruses as a new therapeutic approach in cancer treatment.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
